Cell culturing technology Cellink has bought University of Freiburg's single-cell dispensing spinout Cytena for almost $34m.

UW-founded cancer immunotherapy developer Neoleukin Therapeutics will merge with Aquinox in an all-share deal giving the spinout's shareholders roughly 38.6% equity in the new company.

Quantum Signal has been bought by Ford after two decades of quietly producing technologies for robotic applications including autonomous driving.

Microsoft has bought big data access control software developer BlueTalon, which had raised approximately $26m from investors including Stanford-StartX Fund.

Kinectrics has bought University of Surrey's Gnosys Global in a bid to extend its global presence and unlock the potential of a combined product portfolio.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Boehringer Ingelheim will pay a total of up to $365m to acquire its venture fund's portfolio company Amal Therapeutics, an immunotherapy spinout of University of Geneva.

The deadline for Roche’s $4.3bn purchase of CHOP's gene therapy developer Spark has been postponed until April 2020 amid regulatory scrutiny and pending lawsuits.

Power Resources Group has bought University of Cambridge-founded metal power producer Metalysis, which had plunged into administration last month.

ConnectM Technology has acquired the smart vent maker for an undisclosed sum in a deal that handed an exit to NYU Innovation Fund.